According to our new research study on "Foot and Ankle Care Market Forecast to 2031 -Global Analysis - by Product Type, Condition, End User," the market is anticipated to grow from US$ 16.74 billion in 2024 and is projected to reach US$ 28.38 billion by 2031; it is expected to register a CAGR of 7.9% from 2025 to 2031. The foot and ankle care market growth is attributed to the increasing prevalence of foot and ankle disorders and initiatives for foot and ankle care awareness.

Foot and ankle care refer to the diagnosis, treatment, prevention, and rehabilitation of foot and ankle conditions including injuries, and disorders. This includes care for the bones, joints, muscles, tendons, ligaments, skin, and nails of the lower extremities.

The foot and ankle care market in North America is segmented into the US, Canada, and Mexico. The North America ankle and foot care market is expanding owing to several factors. There is greater use of orthopedic devices, an increase in trauma and fracture cases, and more middle-aged and older patients seeking treatment. The prevalence of low bone density is also rising. For instance, according to a recent report, fractures account for nearly 16% of all musculoskeletal injuries in the US yearly. More than 40% of fractures occur at home. New biodegradable and internal fixation devices are being introduced, and companies are employing various strategies to grow their market presence. For instance, in February 2022, Johnson & Johnson subsidiary DePuy Synthes acquired CrossRoads Extremity Systems.

Properly functioning joints, such as ankles, feet, and legs, are essential for mobility, increasing demand for ankle and foot gadgets. Many top companies, including DePuy Synthes and Stryker Corporation, are influential in this market. Enhanced research and development in North America and advanced technology are driving the market growth. Increased healthcare spending and favorable reimbursement policies improve access to treatments, while better diagnostics allow for early detection of diabetic foot ulcers, enabling more effective care.

FDA clearances for patient-specific implants continually set international safety standards. The restor3D Total Talus Replacement has advanced usage, eventually reducing the time for constant reviews. Regional training programs also attract international fellows who return device preferences to their home markets, reinforcing North America's influence on global consumption practices.

In North America, the US holds a significant share of the foot and ankle care market. The US dominated the North America ankle and foot care market in 2024. The presence of major ankle and foot care players such as Stryker, Zimmer Biomet, Johnson & Johnson, and the rising prevalence of diabetes drive the market. Diabetic foot ulcers are foot injuries in patients with type 1 or type 2 diabetes. According to a recent report by the American Medical Association, nearly one-third of people with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers affect almost 18.6 million people across the globe and 1.6 million in the US annually. About 50% of diabetic foot ulcers become infected, and nearly 20% of those infections result in the amputation of part or all of the foot.

The government has established several trauma centers that specialize in emergencies. According to NCBI, acute ankle sprains are one of the most frequent musculoskeletal ailments, affecting an estimated 2 million people in the US annually. Various foot-related issues, such as ingrown toenails, blisters, injuries, and arthritis, pose a public health concern. According to a report by The American Academy of Orthopaedic Surgeons (AAOS), there are ~43.1 million residents alone in the US who are suffering from foot problems, which means one in every six people is affected. Foot care products include all items necessary for preventing and treating foot and ankle issues. Every human walks about 115,000 miles in their average lifetime, and more than 30% of people face foot problems at some point. Foot care products are essential for sustaining and maintaining proper foot health.

Favorable government policies and regulatory frameworks contribute to the market growth. The US Office of Disease Prevention and Health Promotion launched the "Healthy People 2030" initiative to reduce the incidence of diabetes, its complications, and related deaths. The Food and Drug Administration (FDA) regulates the approval of diabetic foot ulcer treatment in the US. Suitable reimbursement policies increase the accessibility of diabetic foot ulcer treatment for many individuals. The US government offers Medicaid and Medicare services to fund their treatment. The increasing number of clinical trials for ankle and foot devices propels the market.

The market is influenced by several factors, including rising healthcare expenditures globally, the presence of major market players-such as Johnson & Johnson (DePuy Synthes); Acumed, LLC; Stryker Corporation; and Zimmer Biomet Holdings, Inc.-and the growing applications of 3D printing in the healthcare sector.

Personalized Treatments Supported by 3D Printing and Smart Technologies to Provide Market Opportunities in Future

3D printing technology is gaining traction in orthopedic and podiatric applications for creating customized orthotics, prosthetics, and surgical implants. 3D-printed orthotic insoles are customized as per individuals' gait and pressure points to improve comfort, reduce pain, and enhance mobility effectively as compared to traditional insoles. According to the Effect of Foot Insole on Plantar Pressure Distribution in Patients with Neuropathic Diabetic Foot Ulcer study published by MDPI Journals in 2024, custom molded foot orthoses can reduce the plantar pressures by 30-40% as they increase the total contact area by 5-10%. Additionally, 3D-printed titanium implants for complex ankle reconstructions offer a better anatomical fit and reduce the risk of post-operative complications.

Pressure-sensitive insoles, smart shoes, and ankle monitors that track movement patterns, step count, balance, and even early signs of ulcers or joint deterioration are modernizing foot and ankle care with the integration of smart wearable devices. Smart technology is especially useful for monitoring diabetic patients, who are at high risk of foot ulcers and neuropathy. For instance, smart insoles offered by companies such as Orpyx and Podimetrics can detect abnormal pressure zones and send real-time alerts, helping prevent diabetic foot ulcers. Artificial Intelligence (AI) and machine learning are also making inroads by enabling data-driven, personalized treatment plans. AI algorithms can analyze thousands of patient cases to recommend the most effective therapy based on diagnosis, age, activity level, and comorbidities. Furthermore, customized rehabilitation programs using motion-tracking apps and tele-rehab platforms allow patients to recover at home while still being monitored by specialists. Therefore, personalized treatment options supported by 3D printing and smart technologies are emerging as significant trends in the foot and ankle care market.

The US Food and Drug Administration, American Orthopaedic Foot and Ankle Society, Arthritis Foundation, American Podiatric Medical Association, and Our World in data are among the primary and secondary sources referred to while preparing the foot and ankle care market report.